Switzerland-based Sophia Genetics has raised $77 million in an investment round led by Generation Investment Management, bringing the total raised by the firm to $140 million.
The company, which combines expertise in life sciences and medical disciplines with mathematical capabilities in data computing, offers a universal platform, SOPHiA AI, which is used by more than 850 hospitals across 77 countries.
The platform enables healthcare professionals to make sense of complex genomic and radiomic data through advanced analysis in order to better diagnose and treat patients, both for oncology and hereditary disorders.
The money will be used to grow the number of hospitals using its technology, particularly in the USA.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze